Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug trials under way.

Alice Klein

    New Scientist (1971)
    |April 15, 2020
    PubMed
    Summary
    This summary is machine-generated.

    Researchers are investigating if existing HIV and Ebola drugs can effectively treat COVID-19. Clinical trials will soon reveal the efficacy of these repurposed antiviral medications for coronavirus disease 2019.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Profiles of preschoolers' numerical abilities across quantity representations.

    Canadian journal of experimental psychology = Revue canadienne de psychologie experimentale·2024
    Same author

    Design and Analytic Features for Reducing Biases in Skill-Building Intervention Impact Forecasts.

    Journal of research on educational effectiveness·2023
    Same author

    Stress can biologically age you, but the effect isn't permanent.

    New scientist (1971)·2023
    Same author

    Fewer boys born amid covid-19.

    New scientist (1971)·2022
    Same author

    Coronavirus may enter brain via nanotube tunnels.

    New scientist (1971)·2022
    Same author

    Western Australia delays reopening.

    New scientist (1971)·2022

    Area of Science:

    • Virology
    • Infectious Diseases
    • Pharmacology

    Background:

    • COVID-19 (Coronavirus Disease 2019) is a global pandemic caused by the SARS-CoV-2 virus.
    • Existing antiviral drugs have been developed for other viral infections, including Human Immunodeficiency Virus (HIV) and Ebola virus disease.

    Purpose of the Study:

    • To evaluate the potential of repurposed antiviral drugs, originally developed for HIV and Ebola, in treating COVID-19.
    • To determine the clinical efficacy and safety of these repurposed medications against SARS-CoV-2 infection.

    Main Methods:

    • Clinical trials are underway to assess the effectiveness of specific antiviral drugs.
    • Patient outcomes, viral load reduction, and symptom severity are being monitored in trial participants.

    Related Experiment Videos

    Main Results:

    • Results from ongoing clinical trials are pending.
    • The study aims to provide data on whether drugs targeting HIV or Ebola can be repurposed for COVID-19 treatment.

    Conclusions:

    • The findings will inform treatment strategies for COVID-19.
    • Successful repurposing of these drugs could offer accessible and rapid therapeutic options.